BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10228759)

  • 1. Increased blood proinsulin and decreased C-peptide levels in patients with pancreatic cancer.
    Nakamori S; Ishikawa O; Ohigashi H; Sasakuma F; Shimizu T; Nakaizumi A; Furukawa H; Sasaki Y; Imaoka S
    Hepatogastroenterology; 1999; 46(25):16-24. PubMed ID: 10228759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus in pancreatic cancer follow-up.
    Fogar P; Pasquali C; Basso D; Sperti C; Panozzo MP; Tessari G; D'Angeli F; Del Favero G; Plebani M
    Anticancer Res; 1994; 14(6B):2827-30. PubMed ID: 7532931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal and dynamic proinsulin-insulin relationship to assess beta-cell function during OGTT in metabolic disorders.
    Tura A; Pacini G; Kautzky-Willer A; Ludvik B; Prager R; Thomaseth K
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E155-62. PubMed ID: 12670835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proinsulin, insulin, and C-peptide in cystic fibrosis after an oral glucose tolerance test.
    Hartling SG; Garne S; Binder C; Heilmann C; Petersen W; Petersen KE; Koch C
    Diabetes Res; 1988 Apr; 7(4):165-9. PubMed ID: 3042255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired glucose metabolism in colorectal cancer.
    Ehrmann-Jósko A; Siemińska J; Górnicka B; Ziarkiewicz-Wróblewska B; Ziółkowski B; Muszyński J
    Scand J Gastroenterol; 2006 Sep; 41(9):1079-86. PubMed ID: 16938722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired proinsulin secretion before and during oral glucose stimulation in HIV-infected patients who display fat redistribution.
    Haugaard SB; Andersen O; Halsall I; Iversen J; Hales CN; Madsbad S
    Metabolism; 2007 Jul; 56(7):939-46. PubMed ID: 17570256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma glucose, insulin, proinsulin, C-peptide and glucagon before and after a carbohydrate-rich meal in hyperthyroid patients.
    Rovira A; Valdivielso L; Ortega R; Valverde I; Herrera Pombo JL
    Diabete Metab; 1987; 13(4):431-5. PubMed ID: 3315763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma insulin and C-peptide responses to oral glucose load after physical exercise in men with normal and impaired glucose tolerance.
    Nazar K; Kaciuba-Uściłko H; Chwalbińska-Moneta J; Krotkiewski M; Bicz B
    Acta Physiol Pol; 1987; 38(6):458-66. PubMed ID: 3331233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.
    Rosenfalck AM; Fisker S; Hilsted J; Dinesen B; Vølund A; Jørgensen JO; Christiansen JS; Madsbad S
    Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the Ala/Val98 polymorphism of the hepatocyte nuclear factor-1alpha gene and the relationship to beta-cell function during an OGTT in glucose-tolerant women with and without previous gestational diabetes mellitus.
    Lauenborg J; Damm P; Ek J; Glümer C; Jørgensen T; Borch-Johnsen K; Vestergaard H; Hornnes P; Pedersen O; Hansen T
    Diabet Med; 2004 Dec; 21(12):1310-5. PubMed ID: 15569134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of oral glucose tolerance test (OGTT) in output patients with advanced chronic renal failure (CRF)].
    Rufino M; Barbero P; Hernández D; Torres A; Lorenzo V
    Nefrologia; 2007; 27(1):30-7. PubMed ID: 17402877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
    Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
    Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance.
    Xiang GD; Sun HL; Zhao LS; Hou J; Yue L; Xu L
    Clin Endocrinol (Oxf); 2008 May; 68(5):716-23. PubMed ID: 18070144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess glycaemic excursions after an oral glucose tolerance test compared with a mixed meal challenge and self-measured home glucose profiles: is the OGTT a valid predictor of postprandial hyperglycaemia and vice versa?
    Meier JJ; Baller B; Menge BA; Gallwitz B; Schmidt WE; Nauck MA
    Diabetes Obes Metab; 2009 Mar; 11(3):213-22. PubMed ID: 18564177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-peptide pattern in patients with pancreatic cancer.
    Fogar P; Basso D; Panozzo MP; Del Favero G; Briani G; Fabris C; D'Angeli F; Meggiato T; Ferrara C; Plebani M
    Anticancer Res; 1993; 13(6B):2577-80. PubMed ID: 8135497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus.
    Konishi I; Hiasa Y; Shigematsu S; Hirooka M; Furukawa S; Abe M; Matsuura B; Michitaka K; Horiike N; Onji M
    Liver Int; 2009 Sep; 29(8):1194-201. PubMed ID: 19422477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Behavior of C-peptide and immunoreactive insulin in essential obesity].
    Gragnoli G; Signorini AM; Tanganelli I; Martinelli G
    Boll Soc Ital Biol Sper; 1979 Mar; 55(6):564-70. PubMed ID: 399187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV-infected patients.
    Haugaard SB; Andersen O; Hales CN; Halsall I; Rosenfalck AM; Iversen J; Madsbad S
    Eur J Clin Invest; 2006 Jun; 36(6):436-45. PubMed ID: 16684128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study.
    Mavrogiannaki A; Karamanos B; Manesis EK; Papatheodoridis GV; Koskinas J; Archimandritis AJ
    J Viral Hepat; 2009 Jun; 16(6):430-6. PubMed ID: 19200136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
    Gragnoli G; Tanganelli I; Signorini AM
    Boll Soc Ital Biol Sper; 1980 Jan; 56(1):69-75. PubMed ID: 7002168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.